AKT1 and lung adenocarcinoma: For example, in lung adenocarcinoma (LUAD), FBXO32 degrades the cancer suppressor gene PTEN through ubiquitination, removing its inhibition on the PI3K/AKT/mTOR pathway, resulting in abnormal activation of AKT/mTOR signaling.